Provided by Tiger Trade Technology Pte. Ltd.

Mineralys Therapeutics, Inc.

23.63
-0.0900-0.38%
Post-market: 24.000.3700+1.57%19:41 EDT
Volume:928.30K
Turnover:22.06M
Market Cap:2.08B
PE:-5.40
High:24.34
Open:24.01
Low:23.55
Close:23.72
52wk High:47.65
52wk Low:22.30
Shares:88.16M
Float Shares:66.03M
Volume Ratio:0.56
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3763
EPS(LYR):-2.2900
ROE:-80.88%
ROA:-46.18%
PB:3.78
PE(LYR):-10.32

Loading ...

Mineralys Therapeutics director Daphne Karydas sells 3,000 shares valued at $75,000

Reuters
·
Jun 18

Mineralys posts ENDO 2026 lorundrostat biomarker presentation on uncontrolled hypertension

Reuters
·
Jun 15

Mineralys Therapeutics presents late-breaking data on lorundrostat

TIPRANKS
·
Jun 15

Mineralys says lorundrostat reduces heart failure risk biomarkers in post hoc analysis of hypertension trials

Reuters
·
Jun 14

Mineralys CMO David Malcom Rodman disposes of common shares worth $203,512.74

Reuters
·
Jun 13

Mineralys Therapeutics to join Goldman Sachs Global Healthcare Conference fireside chat

Reuters
·
Jun 09

Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

GlobeNewswire
·
Jun 09

Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Mineralys Therapeutics, Inc. (MLYS) and ArriVent BioPharma, Inc. (AVBP)

TIPRANKS
·
Jun 04

Mineralys Therapeutics falls -12.7%

TIPRANKS
·
Jun 03

Mineralys prices offering of 5.66M shares of common stock at $26.50

TIPRANKS
·
Jun 03

BUZZ-U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway

Reuters
·
Jun 03

BUZZ-Mineralys Therapeutics falls after $150 mln stock deal

Reuters
·
Jun 03

BRIEF-Mineralys Therapeutics Announces Pricing Of $150 Million Underwritten Offering Of Common Stock

Reuters
·
Jun 03

Mineralys to repurchase future royalty payments in Tanabe license agreement

TIPRANKS
·
Jun 03

Mineralys Therapeutics prices 5,660,378-share offering at $26.5 per share

Reuters
·
Jun 03

Mineralys inks up to $500 million senior secured term loan with Pharmakon Advisors

Reuters
·
Jun 03

Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing

THOMSON REUTERS
·
Jun 03

Mineralys Therapeutics - Secures $500 Mln Senior Secured Term Loan Facility From Pharmakon Advisors

THOMSON REUTERS
·
Jun 03

Mineralys Therapeutics - Prices $150 Mln Common Stock Offering

THOMSON REUTERS
·
Jun 03

Mineralys Therapeutics - to Repurchase Lorundrostat Royalty Obligation for $200 Mln Upfront, up to $100 Mln in Milestones

THOMSON REUTERS
·
Jun 03